PGRMC1 in animal breast cancer tissue and blood is associated with increased tumor growth with norethisterone in contrast to progesterone and dydrogesterone: four-arm randomized placebo-controlled xenograft study-Reference-Cited by-同舟云学术

PGRMC1 in animal breast cancer tissue and blood is associated with increased tumor growth with norethisterone in contrast to progesterone and dydrogesterone: four-arm randomized placebo-controlled xenograft study

Published:2020-03-25 Issue:11 Volume:36 Page:1024-1027
ISSN:0951-3590
Container-title:Gynecological Endocrinology
language:en
Short-container-title:Gynecological Endocrinology

Author:

Cai Guiju¹^ORCID,Ruan Xiangyan¹²^ORCID,Gu Muqing¹,Zhao Yue¹,Wang Yuejiao¹,Mueck Alfred O.¹²

Affiliation:

1. Department of Gynecological Endocrinology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, China;

2. University Women’s Hospital and Research Centre for Women’s Health, Department of Women's Health, University of Tuebingen, Tuebingen, Germany

Publisher

Informa UK Limited

Subject

Obstetrics and Gynaecology,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.tandfonline.com/doi/pdf/10.1080/09513590.2020.1742689

Reference29 articles.

1. Progesterone, progestins and the breast in menopause treatment

2. Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial

3. Are the progestins responsible for breast cancer risk during hormone therapy in the postmenopause?

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antitumor progestins activity: Cytostatic effect and immune response;Steroids;2024-10

2. The impact of 17β-estradiol on the estrogen-deficient female brain: from mechanisms to therapy with hot flushes as target symptoms;Frontiers in Endocrinology;2024-01-08

3. Overexpression of miR-181a regulates the Warburg effect in triple-negative breast cancer;Climacteric;2022-12-02

4. Clinical importance of PGRMC1 in hormone responsive breast cancer;Breast Care;2022-11-08

5. Optimizing menopausal hormone therapy: for treatment and prevention, menstrual regulation, and reduction of possible risks;Global Health Journal;2022-06